Emerald Mutual Fund Advisers Trust’s Karyopharm Therapeutics KPTI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-743
| Closed | -$117K | – | 231 |
|
|
2021
Q1 | $117K | Sell |
743
-110,006
| -99% | -$17.3M | ﹤0.01% | 207 |
|
|
2020
Q4 | $25.7M | Buy |
110,749
+14,115
| +15% | +$3.28M | 0.89% | 38 |
|
|
2020
Q3 | $21.2M | Buy |
96,634
+27,504
| +40% | +$6.02M | 0.94% | 40 |
|
|
2020
Q2 | $19.6M | Buy |
69,130
+11,415
| +20% | +$3.24M | 0.93% | 41 |
|
|
2020
Q1 | $16.6M | Buy |
57,715
+25,306
| +78% | +$7.29M | 1.04% | 31 |
|
|
2019
Q4 | $9.32M | Sell |
32,409
-63,120
| -66% | -$18.1M | 0.38% | 91 |
|
|
2019
Q3 | $13.8M | Buy |
95,529
+3,836
| +4% | +$554K | 0.61% | 54 |
|
|
2019
Q2 | $8.24M | Sell |
91,693
-72
| -0.1% | -$6.47K | 0.33% | 107 |
|
|
2019
Q1 | $8.04M | Buy |
91,765
+203
| +0.2% | +$17.8K | 0.32% | 114 |
|
|
2018
Q4 | $12.9M | Buy |
91,562
+48,408
| +112% | +$6.8M | 0.6% | 58 |
|
|
2018
Q3 | $11M | Buy |
43,154
+11,308
| +36% | +$2.89M | 0.37% | 102 |
|
|
2018
Q2 | $8.12M | Buy |
+31,846
| New | +$8.12M | 0.29% | 128 |
|